Drugs Disributed by Marshall Isotope Ltd, Israel
Radio-Pharmaceutical. Lutetium (177Lu) Oxodotreotide 370 MBq/ml. VIAL (sol. for infus.): 1. The recomm. tmt. regimen of Lutathera in adult. consists of 4 infus. of 7,400 MBq each. The recom. interval betwn. each admin. is 8 wks. which could be extended up to 16 wks. in case of dose modif. toxic. (DMT).
For renal protect. purpose, an amino acid sol. must be admin. IV during 4 hrs. The infus. of the amino acid sol. should start 30 min. prior to start of Lutetium (177LU) Oxodotreotide infus. See lit.
Tmt. of unresect. / metastat., progres., well different. (G1& G2), somatostatin recept. posit. gastroenteropancreatic neuroendocrine tumours (GEP-NETs) in adult.
C/I: Hypersens. to the active subst. Establish./suspect. pregn. or when pregn. has not been exclud. Renal fail. with Cr/Cl < 30 mL/min.